Degrees Pharmaceuticals, Inc. CONFIDENTIAL All rights reserved. October 2025 1 - 8 - 26 Webinar Disclaimer and Forward - looking Statements 2024 60 Degrees Pharmaceuticals, Inc. CONFIDENTIAL All rights reserved. DISCLAIM
Thursday, January 8, 2026 BiopharmaWatch Research 1 min read
Key Takeaway: Degrees Pharmaceuticals, Inc. has outlined a commercial strategy for its malaria treatment, ARAKODA. The plan includes increasing awareness and differentiating ARAKODA from generic alternatives through targeted marketing efforts. Additionally, the company aims to boost trial usage by engaging more inside sales representatives to prompt healthcare providers to prescribe the medication based on its unique attributes. They are also addressing affordability issues to manage the high out-of-pocket costs for patients, using tools like GoodRx discounts.
Price reaction · baseline $1.9716 (2026-01-07 close) · hit after-hours · clean, no other SXTP news in the window
day 0 close · peak
+4%
Market Sentiment Analysis
POSITIVE FACTORS
A strategic plan to increase awareness of ARAKODA is in place.
Efforts are being made to differentiate ARAKODA from generics.
Plans to encourage healthcare providers to prescribe ARAKODA based on its attributes.
CONCERNS & RISKS
Challenges in increasing the trial and usage of ARAKODA.
Management of high out-of-pocket costs may be a barrier for patients.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+31%
120-day peak, hindsight
Typical move
2.2%
average across 2 past catalysts
Cash runway
~1 mo
High dilution risk
Lead asset
Tafenoquine
Phase 2 · COVID 19 Disease
Full Press Release Details
Commercial Pilot for Malaria Indication Addresses Barriers to Use Increase Awareness and Differentiate ARAKODA D ifferentiate ARAKODA from the generic competition with a clear and compelling value story through different channels Drive ARAKODA Trial & Usage Additional Inside Sales Representatives - Encourage HCPS to prescribe ARAKODA for appropriate patients based on product attributes Facilitate Access & Affordability Manage high OOP through GoodRx point of sale discount
Frequently Asked Questions
How does ARAKODA differentiate from generics?
ARAKODA distinguishes itself from generics with a strong value story communicated through various channels.
What strategies are used to promote ARAKODA?
Strategies include increasing awareness, encouraging healthcare providers to prescribe, and enhancing trial usage.
How is patient access to ARAKODA improved?
Access is improved by managing out-of-pocket costs through GoodRx discounts.
Who promotes ARAKODA to healthcare providers?
Additional Inside Sales Representatives encourage healthcare providers to prescribe ARAKODA.